Amgen, Inc.(NASDAQ:AMGN)’s shares gained 2.65% to $120.97. The company on June 16 announced that it will collaborate with the National Cancer Institute (NCI), part of the...
Amgen, Inc.(NASDAQ:AMGN)’s shares gained 0.70% to $117.82. The company on June 2 announced new data from two key clinical trials that support the potential of talimogene...
OXiGENE Inc (NASDAQ:OXGN)’s stock declined 11.07% to $2.65. The company on May 23 announced that it has entered into definitive agreements with institutional investors to purchase...